Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Buoyant Bayer ups key drug sales forecast

28.02.2014 / Scripintelligence

Adjusted EBITDA in the last three months of 2013 slipped to €1.77bn, dampened by a weak Japanese yen and emerging-market currencies, the company said. The decline was attributed to "substantial negative currency effects, as well as higher research…

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: